Cite
Association Between Risk of Clostridium difficile Infection and Duration of Proton Pump Inhibitor or H2-Receptor Antagonist Use in Hospitalized Patients
MLA
Chien-Huei Huang, et al. “Association Between Risk of Clostridium Difficile Infection and Duration of Proton Pump Inhibitor or H2-Receptor Antagonist Use in Hospitalized Patients.” Infectious Diseases and Therapy, vol. 13, no. 2, Jan. 2024, pp. 373–83. EBSCOhost, https://doi.org/10.1007/s40121-024-00922-5.
APA
Chien-Huei Huang, Yung-Hsin Tseng, Wen-Shan Tsai, Chien-Chou Su, Ching-Lan Cheng, Yea-Huei Kao Yang, Yu-Ching Chang, & Yi-Hsuan Liu. (2024). Association Between Risk of Clostridium difficile Infection and Duration of Proton Pump Inhibitor or H2-Receptor Antagonist Use in Hospitalized Patients. Infectious Diseases and Therapy, 13(2), 373–383. https://doi.org/10.1007/s40121-024-00922-5
Chicago
Chien-Huei Huang, Yung-Hsin Tseng, Wen-Shan Tsai, Chien-Chou Su, Ching-Lan Cheng, Yea-Huei Kao Yang, Yu-Ching Chang, and Yi-Hsuan Liu. 2024. “Association Between Risk of Clostridium Difficile Infection and Duration of Proton Pump Inhibitor or H2-Receptor Antagonist Use in Hospitalized Patients.” Infectious Diseases and Therapy 13 (2): 373–83. doi:10.1007/s40121-024-00922-5.